Open AccessIsolated peritoneal carcinomatosis in prostate cancer: from a successful hormonal management to a review of the literature
Author(s) -
Emilie Delchambre,
Stéphane Rysselinck,
Géraldine Pairet,
Caterina Confente,
Emmanuel Seront
Publication year - 2021
Publication title -
future science oa
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.825
H-Index - 23
ISSN - 2056-5623
DOI - 10.2144/fsoa-2021-0009
Subject(s) - medicine , prostate cancer , prostate , cancer , disease , hormonal therapy , peritoneal carcinomatosis , carcinosis , pathology , androgen deprivation therapy , lesion , hormone , oncology , colorectal cancer
Metastases from prostate cancer involve mainly the bone compartment. However, visceral metastases are found in up to 49% of metastatic patients, occurring mainly in late stages of the disease, and are correlated with poor outcome. Peritoneal carcinomatosis is rarely described in literature, particularly when not associated with other distant metastatic lesions. We present the management of a patient with prostate cancer progressing on androgen deprivation therapy with description of omental involvement on 68 Ga PSMA-PET. There was no ascite or other distant lesion, reflecting thus a specific tropism of the cancer in this patient who had no history of prostate surgery. Abiraterone acetate resulted in a long-lasting complete response. We also present a review focusing on this entity.